Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory Diseases
Mesenchymal stem cells (MSCs) have been broadly used as a therapy for autoimmune disease in both animal models and clinical trials. MSCs inhibit T effector cells and many other immune cells, while activating regulatory T cells, thus reducing the production of pro-inflammatory cytokines, including tu...
Main Authors: | Li Yan, Dejin Zheng, Ren-He Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01658/full |
Similar Items
-
Control and induction of tumor necrosis factor and its receptors on human lymphocytes: a critical structure for immune regulation
by: Tahhan, Georges
Published: (2016) -
Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders
by: Yun Dong, et al.
Published: (2015-11-01) -
Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
by: Benoît L. Salomon, et al.
Published: (2018-03-01) -
Comparison the function of Cyprinid herpesvirus 3 encoded two viral tumor necrosis factor receptors
by: Yaojia Zhou, et al.
Published: (2021-11-01) -
Size-Dependent Effect of Silver Nanoparticles on the Tumor Necrosis Factor α-Induced DNA Damage Response
by: Alaa Fehaid, et al.
Published: (2019-02-01)